| Code | 0712F | ||||||||||
| MA number | 24/0247/25-S | ||||||||||
| Product Form: | tbl 30x20 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Medreg s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 24 - ANTIHISTAMINICA, HISTAMIN | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 09.08.2025 |
| Validity: | 09.08.2030 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Bilastine Medreg_OTC_07.2025.pdf
|
| PIL: |
PIL_Bilastine Medreg_Rx_07.2025.pdf
|
| SPC: |
SPC_Bilastine Medreg_07.2025.pdf
|
| Safety feature | Yes |
| Data update: | 12.08.2025 |
